{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:22:10Z","timestamp":1773282130193,"version":"3.50.1"},"reference-count":11,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.ophtha.2005.06.035","type":"journal-article","created":{"date-parts":[[2005,10,13]],"date-time":"2005-10-13T09:45:49Z","timestamp":1129196749000},"page":"2143.e1-2143.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Side-Effect Profile of Brimonidine Tartrate in Children"],"prefix":"10.1016","volume":"112","author":[{"given":"Sami","family":"Al-Shahwan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah A.","family":"Al-Torbak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahira","family":"Turkmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamdouh","family":"Al-Omran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Al-Jadaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak P.","family":"Edward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2005.06.035_bib1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1067\/mpd.2002.120816","article-title":"Failure of naloxone to reverse brimonidine-induced coma in an infant","volume":"140","author":"Sztajnbok","year":"2002","journal-title":"J Pediatr"},{"key":"10.1016\/j.ophtha.2005.06.035_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1067\/mpa.2001.117571","article-title":"Safety and efficacy of brimonidine in children with glaucoma","volume":"5","author":"Enyedi","year":"2001","journal-title":"J AAPOS"},{"key":"10.1016\/j.ophtha.2005.06.035_bib3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1067\/mpd.2001.111319","article-title":"Ophthalmic drops causing coma in an infant","volume":"138","author":"Berlin","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.ophtha.2005.06.035_bib4","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/eye.1999.235","article-title":"Severe systemic toxicity caused by brimonidine drops in an infant with presumed juvenile xanthogranuloma","volume":"13","author":"Walters","year":"1999","journal-title":"Eye"},{"key":"10.1016\/j.ophtha.2005.06.035_bib5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/sj.eye.6700520","article-title":"Ocular and systemic side effects of brimonidine 0.2% eye drops (Alphagan) in children","volume":"18","author":"Bowman","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.ophtha.2005.06.035_bib6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0002-9394(99)00083-5","article-title":"Apparent central nervous system depression in infants after the use of topical brimonidine","volume":"128","author":"Carlsen","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.06.035_bib7","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0161-6420(97)30314-5","article-title":"Validation of a questionnaire for comparing the tolerability of ophthalmic medications","volume":"104","author":"Barber","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2005.06.035_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0149-2918(00)87981-3","article-title":"Ongoing clinical assessment of the safety profile and efficacy of brimonidine compared with timolol","volume":"22","author":"Melamed","year":"2000","journal-title":"Clin Ther"},{"key":"10.1016\/j.ophtha.2005.06.035_bib9","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0022-3565(25)38830-0","article-title":"Density of alpha-2A adrenoceptors and Gi proteins in the human brain","volume":"269","author":"Sastre","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ophtha.2005.06.035_bib10","first-page":"471","article-title":"Alpha 2-adrenoceptors in the brain of suicide victims","volume":"31","author":"Meana","year":"1992","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.ophtha.2005.06.035_bib11","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00061198-200106000-00014","article-title":"Effectiveness and safety of brimonidine as adjunctive therapy for patients with elevated intraocular pressure in a large open-label community trial","volume":"10","author":"Lee","year":"2001","journal-title":"J Glaucoma"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642005009243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642005009243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:50:40Z","timestamp":1758981040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642005009243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":11,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0161642005009243"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2005.06.035","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Side-Effect Profile of Brimonidine Tartrate in Children","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2005.06.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}